浙江医学
浙江醫學
절강의학
ZHEJIANG MEDICAL JOURNAL
2014年
4期
285-288
,共4页
庄晓苹%林琼琼%陈国荣%董迎
莊曉蘋%林瓊瓊%陳國榮%董迎
장효평%림경경%진국영%동영
表皮生长因子受体%子宫内膜样腺癌%免疫组化%原位杂交%实时荧光定量PCR
錶皮生長因子受體%子宮內膜樣腺癌%免疫組化%原位雜交%實時熒光定量PCR
표피생장인자수체%자궁내막양선암%면역조화%원위잡교%실시형광정량PCR
Epidermal growth factor receptor%Endometrial adenocarcinoma%Immunohistochemistry%In situ hy-bridization%QRT- PCR
目的:研究表皮生长因子受体(EGFR)在子宫内膜样腺癌中的表达及意义。方法采用免疫组化、原位杂交和实时荧光定量PCR方法检测正常子宫内膜组织20例、不典型增生子宫内膜组织20例、子宫内膜样腺癌组织60例的EGFR蛋白、mRNA和基因表达。结果子宫内膜样腺癌组EGFR蛋白和mRNA表达高于正常子宫内膜组,差异有统计学意义(P<0.01);不典型增生子宫内膜组EGFR蛋白和mRNA表达高于正常子宫内膜组,但差异无统计学意义(P>0.05);子宫内膜样腺癌组EGFR蛋白和mR-NA表达高于不典型增生子宫内膜组,但差异无统计学意义(P>0.05)。子宫内膜样腺癌组EGFR相对表达量高于正常子宫内膜组,差异有统计学意义(P<0.05),但不典型增生子宫内膜组和正常子宫内膜组比较,差异无统计学意义(P>0.05)。结论 EGFR的过度表达参与子宫内膜样腺癌的发生、发展过程。
目的:研究錶皮生長因子受體(EGFR)在子宮內膜樣腺癌中的錶達及意義。方法採用免疫組化、原位雜交和實時熒光定量PCR方法檢測正常子宮內膜組織20例、不典型增生子宮內膜組織20例、子宮內膜樣腺癌組織60例的EGFR蛋白、mRNA和基因錶達。結果子宮內膜樣腺癌組EGFR蛋白和mRNA錶達高于正常子宮內膜組,差異有統計學意義(P<0.01);不典型增生子宮內膜組EGFR蛋白和mRNA錶達高于正常子宮內膜組,但差異無統計學意義(P>0.05);子宮內膜樣腺癌組EGFR蛋白和mR-NA錶達高于不典型增生子宮內膜組,但差異無統計學意義(P>0.05)。子宮內膜樣腺癌組EGFR相對錶達量高于正常子宮內膜組,差異有統計學意義(P<0.05),但不典型增生子宮內膜組和正常子宮內膜組比較,差異無統計學意義(P>0.05)。結論 EGFR的過度錶達參與子宮內膜樣腺癌的髮生、髮展過程。
목적:연구표피생장인자수체(EGFR)재자궁내막양선암중적표체급의의。방법채용면역조화、원위잡교화실시형광정량PCR방법검측정상자궁내막조직20례、불전형증생자궁내막조직20례、자궁내막양선암조직60례적EGFR단백、mRNA화기인표체。결과자궁내막양선암조EGFR단백화mRNA표체고우정상자궁내막조,차이유통계학의의(P<0.01);불전형증생자궁내막조EGFR단백화mRNA표체고우정상자궁내막조,단차이무통계학의의(P>0.05);자궁내막양선암조EGFR단백화mR-NA표체고우불전형증생자궁내막조,단차이무통계학의의(P>0.05)。자궁내막양선암조EGFR상대표체량고우정상자궁내막조,차이유통계학의의(P<0.05),단불전형증생자궁내막조화정상자궁내막조비교,차이무통계학의의(P>0.05)。결론 EGFR적과도표체삼여자궁내막양선암적발생、발전과정。
Objective To investigate the expression of EGFR in endometrial adenocarcinoma and its clinical significance. Methods The expression of EGFR protein and mRNA were detected by immunohistochemistry, in situ hybridization and re-al- time quantitative reverse transcription- polymerase chain reaction (QRT- PCR) respectively, in 20 cases of normal endometri-um, 20 cases of atypical endometrial hyperplasia and 60 cases of endometrial adenocarcinoma. Results The expressions of EGFR protein and mRNA were higher in endometrial adenocarcinoma than those in normal endometrium(P<0.01). There were no significant differences in expression of EGFR protein and mRNA both between normal endometrium and atypical endometrial hy-perplasia, and between adenocarcinoma and atypical hyperplasia(P>0.05). Conclusion The over- expression of EGFR may be involved in the occurrence and development of endometrial adenocarcinoma.